IPMN, PANCREATIC
Clinical trials for IPMN, PANCREATIC explained in plain language.
Never miss a new study
Get alerted when new IPMN, PANCREATIC trials appear
Sign up with your email to follow new studies for IPMN, PANCREATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to slash deadly leaks after pancreatic cancer surgery
Disease control Recruiting nowThis trial tests whether giving three treatments together—two medicines and a surgical patch—can lower the risk of major complications after Whipple surgery for pancreatic cancer and other tumors. The study includes 400 high-risk patients with a small pancreatic duct. If successf…
Matched conditions: IPMN, PANCREATIC
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New laser blood test could spot pancreatic cancer early
Diagnosis Recruiting nowThis study is testing a new laser-based blood test that uses nanoparticles to detect pancreatic cancer early. Researchers will enroll 400 people, including those with diabetes, pancreatic cysts, or pancreatic cancer, to see if the test can accurately identify cancer. The goal is …
Matched conditions: IPMN, PANCREATIC
Phase: NA • Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Diagnosis
Last updated Jun 27, 2026 14:01 UTC
-
AI reads CT scans to spot pancreatic cancer faster
Diagnosis Recruiting nowThis study tests an artificial intelligence (AI) system that analyzes contrast-enhanced CT scans to help diagnose and manage pancreatic diseases. The AI will classify patients into three groups: needing immediate treatment, close monitoring, or routine follow-up. Researchers will…
Matched conditions: IPMN, PANCREATIC
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Scientists hunt for new treatments for liver metastases in colorectal and pancreatic cancers
Knowledge-focused Recruiting nowThis study aims to understand why liver metastases are so deadly in colorectal and pancreatic cancers. Researchers will analyze tumors and blood from 625 participants to find new targets for immune and gene therapies. The goal is to develop better treatments for these hard-to-tre…
Matched conditions: IPMN, PANCREATIC
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
New study aims to reduce unnecessary pancreatic surgery with smarter biomarkers
Knowledge-focused Recruiting nowThis study is looking for new biomarkers to tell which pancreatic cysts (IPMNs) are likely to become cancerous. Researchers will analyze genetic, metabolic, and lifestyle data from 800 patients to develop a risk score. The goal is to help doctors decide who truly needs surgery an…
Matched conditions: IPMN, PANCREATIC
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Can a simple blood test predict which pancreatic cysts turn cancerous?
Knowledge-focused Recruiting nowThis study is looking for biological markers in the blood and tissue that can tell apart harmless pancreatic cysts (IPMN) from those that are likely to turn into pancreatic cancer. Researchers will follow 3,600 patients with IPMN across four Italian hospitals, collecting blood sa…
Matched conditions: IPMN, PANCREATIC
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:08 UTC